298. Hereditary pancreatitis
93 clinical trials,   168 drugs   (DrugBank: 51 drugs),   48 drug target genes,   134 drug target pathways

Searched query = "Hereditary pancreatitis", "Chronic pancreatitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00620919
(ClinicalTrials.gov)
February 200822/1/2008Secretin Enhanced Multidetector CT Pancreatography for Evaluation of Known or Suspected Chronic PancreatitisRG1068 (Synthetic Human Secretin) Enhanced Multidetector CT Pancreatography: Evaluation of the Pancreatic Duct in Patients With Known or Suspected Chronic PancreatitisChronic PancreatitisDrug: RG1068 (Synthetic Human Secretin)Massachusetts General HospitalNULLTerminated18 Years90 YearsBoth0Phase 1United States
2NCT00621283
(ClinicalTrials.gov)
February 200822/1/2008Secretin Enhanced MRCP for Evaluation of Pancreatic Duct in Pediatric PopulationRG1068 (Synthetic Human Secretin) Enhanced MRCP for Morphological Evaluation of the Pancreatic Duct in the Pediatric PopulationAcute Recurrent Pancreatitis;Chronic PancreatitisDrug: RG1068 (Synthetic Human Secretin)Massachusetts General HospitalNULLTerminated2 Years18 YearsBoth0Phase 1United States